Endometrial Adenosquamous Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Adenosquamous Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib S-Malate in recurrent or metastatic endometrial cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating three regimens for endometrial cancer: paclitaxel-carboplatin-bevacizumab, paclitaxel-carboplatin-temsirolimus, and…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in patients with recurrent or persistent endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial of trebananib for persistent or recurrent endometrial cancer has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer [Phase 2]
Phase 2 trial evaluating MK2206, an Akt inhibitor, in recurrent or advanced endometrial cancer; study completed with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate for recurrent or persistent endometrial cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus [Phase 2]
A Phase 2 clinical trial evaluated medroxyprogesterone acetate for treating endometrial cancers, including endometrial adenocarcinoma and re…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer [Phase 2]
This Phase II clinical trial update evaluates a multimodal therapy consisting of intensity-modulated radiation therapy with cisplatin and be…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial of selumetinib in recurrent or persistent endometrial cancer has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating thalidomide in patients with recurrent or persistent endometrial cancer has completed.